BMJ Open (Jun 2019)

Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children

  • Lauren Maxwell,
  • Gabriel Carles,
  • Véronique Lambert,
  • Arnaldo Prata-Barbosa,
  • Laura C Rodrigues,
  • Ludovic Reveiz,
  • Annelies Wilder-Smith,
  • Yinghui Wei,
  • Thalia Velho Barreto de Araújo,
  • Maria VanKerkhove,
  • Celina Maria Turchi Martelli,
  • Marília Dalva Turchi,
  • Mauro Teixeira,
  • Adriana Tami,
  • João Souza,
  • Patricia Sousa,
  • Antoni Soriano-Arandes,
  • Carmen Soria-Segarra,
  • Kerstin Daniela Rosenberger,
  • Léo Pomar,
  • Luiza Emylce Pelá Rosado,
  • Freddy Perez,
  • Saulo D. Passos,
  • Mauricio Nogueira,
  • Trevor P. Noel,
  • Antônio Moura da Silva,
  • Maria Elisabeth Moreira,
  • Ivonne Morales,
  • Maria Consuelo Miranda Montoya,
  • Calum N. L. Macpherson,
  • Zhiyi Lan,
  • Angelle Desiree LaBeaud,
  • Marion Koopmans,
  • Caron Kim,
  • Esaú João,
  • Thomas Jaenisch,
  • Cristina Barroso Hofer,
  • Patrick Gérardin,
  • Jucelia S. Ganz,
  • Ana Carolina Fialho Dias,
  • Vanessa Elias,
  • Geraldo Duarte,
  • Thomas Paul Alfons Debray,
  • María Luisa Cafferata,
  • Pierre Buekens,
  • Nathalie Broutet,
  • Elizabeth B. Brickley,
  • Patrícia Brasil,
  • Fátima Brant,
  • Sarah Bethencourt,
  • Vivian Lida Avelino-Silva,
  • Antonio Alves da Cunha,
  • Jackeline Alger,
  • Liège Maria Abreu de carvalho,
  • Rosangela Batista,
  • Ana Paula Bertozzi,
  • Denise Cotrim,
  • Luana Damasceno,
  • Lady Dimitrakis,
  • María Manoela Duarte rodrigues,
  • Cassia F Estofolete,
  • Maria Isabel Fragoso da silveira gouvêa,
  • Vicky Fumadó-pérez,
  • Neely Kaydos-daniels,
  • Suzanne Gilboa,
  • Amy Krystosik,
  • Milagros García López-hortelano,
  • Marisa Marcia Mussi-pinhata,
  • Christina Nelson,
  • Karin Nielsen,
  • Denise M Oliani,
  • Renata Rabello,
  • Marizelia Ribeiro,
  • Barry Rockx,
  • Silvia Salgado,
  • Katia Silveira,
  • Elena Sulleiro,
  • Van Tong,
  • Diana Valencia,
  • Wayner Vieira De souza,
  • Luis Angel Villar centeno,
  • Andrea Zin

DOI
https://doi.org/10.1136/bmjopen-2018-026092
Journal volume & issue
Vol. 9, no. 6

Abstract

Read online

IntroductionZika virus (ZIKV) infection during pregnancy is a known cause of microcephaly and other congenital and developmental anomalies. In the absence of a ZIKV vaccine or prophylactics, principal investigators (PIs) and international leaders in ZIKV research have formed the ZIKV Individual Participant Data (IPD) Consortium to identify, collect and synthesise IPD from longitudinal studies of pregnant women that measure ZIKV infection during pregnancy and fetal, infant or child outcomes.Methods and analysisWe will identify eligible studies through the ZIKV IPD Consortium membership and a systematic review and invite study PIs to participate in the IPD meta-analysis (IPD-MA). We will use the combined dataset to estimate the relative and absolute risk of congenital Zika syndrome (CZS), including microcephaly and late symptomatic congenital infections; identify and explore sources of heterogeneity in those estimates and develop and validate a risk prediction model to identify the pregnancies at the highest risk of CZS or adverse developmental outcomes. The variable accuracy of diagnostic assays and differences in exposure and outcome definitions means that included studies will have a higher level of systematic variability, a component of measurement error, than an IPD-MA of studies of an established pathogen. We will use expert testimony, existing internal and external diagnostic accuracy validation studies and laboratory external quality assessments to inform the distribution of measurement error in our models. We will apply both Bayesian and frequentist methods to directly account for these and other sources of uncertainty.Ethics and disseminationThe IPD-MA was deemed exempt from ethical review. We will convene a group of patient advocates to evaluate the ethical implications and utility of the risk stratification tool. Findings from these analyses will be shared via national and international conferences and through publication in open access, peer-reviewed journals.Trial registration numberPROSPERO International prospective register of systematic reviews (CRD42017068915).